MASON STREET ADVISORS, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASON STREET ADVISORS, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2020$1,629,000
+2.6%
95,812
+0.1%
0.03%
-9.7%
Q3 2020$1,588,000
-29.7%
95,750
-1.8%
0.03%
-32.6%
Q2 2020$2,259,000
+35.3%
97,538
+4.2%
0.05%
+17.9%
Q1 2020$1,670,000
-17.3%
93,5700.0%0.04%0.0%
Q4 2019$2,020,000
+344.0%
93,570
+274.7%
0.04%
+290.0%
Q3 2019$455,000
-48.5%
24,971
+0.5%
0.01%
-47.4%
Q2 2019$884,000
+5.9%
24,859
+0.1%
0.02%
+11.8%
Q1 2019$835,000
+4.1%
24,838
+1.8%
0.02%
-15.0%
Q4 2018$802,000
-45.7%
24,402
+0.6%
0.02%
-35.5%
Q3 2018$1,478,000
+33.9%
24,245
+7.3%
0.03%
+24.0%
Q2 2018$1,104,000
-53.7%
22,605
+0.8%
0.02%
-55.4%
Q1 2018$2,382,000
-2.6%
22,416
-45.3%
0.06%0.0%
Q4 2017$2,446,000
+157.5%
40,956
+3.4%
0.06%
+143.5%
Q3 2017$950,000
+27.0%
39,593
+3.5%
0.02%
+21.1%
Q2 2017$748,000
-11.4%
38,261
+6.4%
0.02%
-13.6%
Q1 2017$844,000
+105.9%
35,971
+7.7%
0.02%
+100.0%
Q4 2016$410,000
-15.3%
33,397
+18.6%
0.01%
-21.4%
Q3 2016$484,000
+27.7%
28,148
+5.7%
0.01%
+27.3%
Q2 2016$379,000
+14.2%
26,638
+10.2%
0.01%
+10.0%
Q1 2016$332,000
-8.3%
24,165
+12.3%
0.01%
-9.1%
Q4 2015$362,000
+69.2%
21,509
+10.3%
0.01%
+57.1%
Q3 2015$214,000
+1.4%
19,502
+15.8%
0.01%
+16.7%
Q2 2015$211,00016,8380.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders